Industry Interview from Pharma IQ's 4th Annual Packaging and Labelling Forum Resource Centre: Can a Label Change Your Patient's Behaviour?

LONDON, May 16, 2014 /PRNewswire/ --

Is it really possible to develop labelling that is legally compliant, commercially viable, and influence a patient's behaviour?

Pharma IQ recently worked with Dr. Karel van der Waarde, to review this question. The following article is the result - it addresses the recent falsification and pharmacovigilance regulations - we thought it might be of interest:

Falsification and Pharmacovigilance: What Do Patients Get to See and What Should They Do with It?

The article highlights the discrepancy between the expectations of the legislation, and the reactions of patients. As well as focusing on user actions, relevant criteria, process, and performance levels instead of 'assuming that additional visual information will somehow modify the behaviour of people'.

Please download the article here: http://bit.ly/Falsificationcontent

You can find out more about the challenges of implementing the latest pharmaceutical packaging and labelling regulations at Pharma IQ's 4th Annual Packaging and Labelling forum on 10-12 June in Basel. Please download the programme for more information here: http://bit.ly/Brochurepackandlabel

The Pharmaceutical Packaging and Labelling Summit will take place on 8-10th June 2014 in Basel. Find the full programme, speaker list and registration form at http://bit.ly/Brochurepackandlabel,
call +44(0)20-7036-1300 or email enquire@iqpc.co.uk.

Press are invited to attend this key industry event. If you would like a complimentary press pass please email Elena Patten at: enquire@iqpc.co.uk  

Media contact: Elena Patten, Tel: +44(0)20-7368-9300, Email: enquire@iqpc.co.uk or visit: http://bit.ly/homepackandlable